Jun 16, 2026 04:06PM
Jun 16, 2026 04:05PM
Jun 12, 2026 08:01AM
Jun 12, 2026 08:00AM
Jun 4, 2026 07:45AM
Jun 4, 2026 07:45AM
May 27, 2026 05:00PM Jazz Pharmaceuticals publishes cancer trial results in medical journal
May 27, 2026 05:00PM
May 5, 2026 04:05PM
Apr 27, 2026 07:45AM
Apr 27, 2026 07:45AM
Apr 21, 2026 04:05PM
Apr 9, 2026 07:45AM
Mar 24, 2026 01:49PM American Nutrition Association Announces Initiative with Jazz Pharmaceuticals to Advance Evidence-Based Sodium Reduction and Cardiovascular Health Education
Mar 18, 2026 07:44AM
Feb 24, 2026 04:05PM
Jan 12, 2026 07:06AM
Jan 12, 2026 07:05AM
Jan 6, 2026 01:33PM
Jan 6, 2026 01:32PM
Dec 5, 2025 09:01AM Jazz Pharmaceuticals to present Epidiolex data at epilepsy conference
Dec 5, 2025 09:00AM
Dec 2, 2025 04:05PM
Dec 2, 2025 04:05PM
Nov 18, 2025 04:59AM
Nov 17, 2025 06:00AM
Nov 17, 2025 06:00AM
Nov 11, 2025 07:45AM Jazz Pharmaceuticals presents Modeyso data at neuro-oncology meeting
Nov 11, 2025 07:45AM
Nov 5, 2025 04:05PM
Oct 3, 2025 08:05AM
Oct 2, 2025 06:38PM
Oct 2, 2025 06:37PM
Oct 2, 2025 03:33PM
Sep 22, 2025 07:45AM Jazz Pharmaceuticals presents Xywav data at medical conferences
Sep 22, 2025 07:45AM
Sep 11, 2025 08:18AM
Sep 9, 2025 07:45AM
Sep 9, 2025 07:45AM
Aug 20, 2025 04:15PM
Aug 6, 2025 03:08PM
Aug 6, 2025 03:07PM Jazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma
Aug 6, 2025 02:24PM
Aug 5, 2025 04:05PM
Jul 1, 2025 08:32AM
Jul 1, 2025 08:31AM
Jun 11, 2025 07:15AM
Jun 10, 2025 07:05AM
Jun 10, 2025 07:05AM Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination Granted U.S. FDA Priority Review for First-Line Maintenance Treatment of Extensive-Stage Small Cell Lung Cancer
Jun 9, 2025 06:27PM

325,297 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All